申请人:Boehringer Ingelheim International GmbH
公开号:US20210292301A1
公开(公告)日:2021-09-23
Disclosed are heteroaromatic carboxamides of formula (I),
wherein Y, R, and Ar are as defined herein, and pharmaceutically acceptable salts thereof. Also disclosed are the use of the compounds of formula (i) for the treatment of diseases which can be influenced by the inhibition of plasma kallikrein.